by Danielle Bonadies | Jan 31, 2020 | News
Last week, three House Democrats called on the Department of Homeland Security (DHS) to stop collecting DNA from migrants in government custody. Democratic Reps. Rashida Tlaib (MI), Veronica Escobar (TX), and Congressional Hispanic Caucus...
by Danielle Bonadies | Jan 24, 2020 | News
A few months ago, I received an email from a company called Chronomics that tests for epigenetic changes in your DNA. I’m still a bit scarred from my personal direct-to-consumer testing experience, so I was initially reluctant to explore yet another genetic...
by Danielle Bonadies | Jan 9, 2020 | News
Since its launch in 2013, ClinVar has not only amassed a wealth of genetic variant information, but the lab and clinical genetics community in the US are readily referencing it when they have questions about the clinical significance of variants. A few healthcare...
by Danielle Bonadies | Jan 2, 2020 | News
2019 was another banner year for precision oncology with the approval of a number of drugs targeting novel genomic alterations, the availability of a third pan-cancer indication, and the commercial launch of new biomarker tests for predicting drug response, such as...
by Danielle Bonadies | Jan 2, 2020 | News
In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether...